Effectiveness of SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on DMARDs: as determined by antibody and T cell responses

OBJECTIVES: To assess antibody and T cell responses to SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on disease-modifying antirheumatic drugs (DMARDs). METHODS: This prospective study recruited 100 patients with RA on a variety of DMARDs for antibody and T cell analysis, pre-vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: Saleem, Benazir, Ross, Rebecca L, Bissell, Lesley-Anne, Aslam, Aamir, Mankia, Kulveer, Duquenne, Laurence, Corsadden, Diane, Carter, Clive, Hughes, Pam, Nadat, Fatima A, Mulipa, Panji, Lobb, Mark, Clarke, Brendan, Mbara, Katie, Morton, Ruth, Dibb, Sophie, Chowdhury, Rahaymin, Newton, Darren, Pike, Alexandra, Kakkar, Vishal, Savic, Sinisia, DelGaldo, Francesco, Emery, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977455/
https://www.ncbi.nlm.nih.gov/pubmed/35365569
http://dx.doi.org/10.1136/rmdopen-2021-002050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977455/
https://www.ncbi.nlm.nih.gov/pubmed/35365569
http://dx.doi.org/10.1136/rmdopen-2021-002050

Ejemplares similares